THE CLINICAL UTILITY OF RADIOLABELED GOAT AND PRIMATE ANTI-CEA SERA IN THE LOCALIZATION OF PRIMARY AND METASTATIC CARCINOMA

被引：0
|
作者：
SILVA, JS
COX, CE
SULLIVAN, DS
机构：
[1] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT RADIOL,DURHAM,NC 27710
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1980年 / 21卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：239 / 239
页数：1
相关论文
共 43 条
  • [31] ANTIBODY-GUIDED DETECTION OF PRIMARY MEDULLARY CARCINOMA BY MEANS OF IN-111 LABELED ANTI-CEA MONOCLONAL-ANTIBODY - A CASE-REPORT
    MOSCATELLI, G
    AGOSTINI, M
    BENINI, S
    PAGANELLI, G
    RIVA, P
    TISON, V
    BRITISH JOURNAL OF CANCER, 1986, 54 (03) : 554 - 554
  • [32] EFFECT OF DOSE ESCALATION OF A MONOCLONAL ANTI-CEA IGG ON TUMOR-LOCALIZATION AND TISSUE DISTRIBUTION IN NUDE-MICE XENOGRAFTED WITH HUMAN-COLON CARCINOMA
    ROGERS, GT
    PEDLEY, RB
    BODEN, J
    HARWOOD, PJ
    BAGSHAWE, KD
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1986, 23 (02) : 107 - 112
  • [33] THE IMMUNOSCINTIGRAPHIC USE OF TC-99M-LABELED MONOCLONAL ANTI-CEA ANTIBODIES (BW 431/26) IN PATIENTS WITH SUSPECTED PRIMARY, RECURRENT AND METASTATIC BREAST-CANCER
    LIND, P
    SMOLA, MG
    LECHNER, P
    RATSCHEK, M
    KLIMA, G
    KOLTRINGER, P
    STEINDORFER, P
    EBER, O
    INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (06) : 865 - 869
  • [34] LOCALIZATION OF COLON-CARCINOMA BY EMISSION COMPUTERIZED-TOMOGRAPHY (ECT) USING I-123 LABELED F(AB')2 FRAGMENTS FROM MONOCLONAL ANTI-CEA ANTIBODIES
    GROB, JP
    DELALOYE, B
    BISCHOFDELALOYE, A
    BUCHEGGER, F
    HALPERN, S
    PETTAVEL, J
    BESSON, A
    MOSIMANN, F
    BARRELET, L
    VONFLIEDNER, V
    MACH, JP
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (03): : 402 - 402
  • [35] Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma:: Two-year follow-up
    Lacic, M
    Bokulic, T
    Lukac, J
    Baum, RP
    Kusic, Z
    NUCLEAR MEDICINE COMMUNICATIONS, 1999, 20 (09) : 859 - 865
  • [36] Clinical utility of EBUS-TBNA sampling in the diagnosis of metastatic non-lung primary carcinoma at a UK teaching hospital
    Gillott, Robert
    Noor, Muhammad
    Rana, Durgesh
    Nash, Sarah
    Shelton, David
    Narine, Nadira
    Thiryayi, Sakina
    Al-Najjar, Haider
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [37] Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
    Bodet-Milin, Caroline
    Faivre-Chauvet, Alain
    Carlier, Thomas
    Ansquer, Catherine
    Rauscher, Aurore
    Frampas, Eric
    Toulgoat, Frederique
    Masson, Damien
    Bourgeois, Mickael
    Cerato, Evelyne
    Rohmer, Vincent
    Couturier, Olivier
    Drui, Delphine
    Goldenberg, David M.
    Sharkey, Robert M.
    Barbet, Jacques
    Kraeber-Bodere, Francoise
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (09) : 1221 - 1227
  • [38] Primary anti-VEGF-refractory metastatic renal cell carcinoma (mRCC): Clinical characteristics, risk factors, and subsequent therapy
    Heng, D. Y.
    MacKenzie, M. J.
    Vaishampayan, U. N.
    Knox, J. J.
    Bjarnason, G. A.
    Tan, M.
    Wood, L.
    Donskov, F.
    Rini, B. I.
    Choueiri, T. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [39] Clinical relevance of immunoscintigraphy with Tc-99m-labelled anti-CEA antigen-binding fragments in the follow-up of patients with colorectal carcinoma. Assessment of resectability by a combination of conventional imaging methods
    Behr, TM
    Becker, W
    Goldenberg, DM
    Scheele, JR
    Wolf, FG
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 122 (15) : 463 - 470
  • [40] PRIMARY AND METASTATIC BREAST-CARCINOMA - INITIAL CLINICAL-EVALUATION WITH PET WITH THE RADIOLABELED GLUCOSE ANALOG 2-[F-18]-FLUORO-2-DEOXY-D-GLUCOSE
    WAHL, RL
    CODY, RL
    HUTCHINS, GD
    MUDGETT, EE
    RADIOLOGY, 1991, 179 (03) : 765 - 770
12345